Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efalizumab for Moderate to Severe Atopic Dermatitis - A Phase I Pilot Study in Adults

NCT00226057 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT00226057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00226057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efalizumab for Moderate to Severe Atopic Dermatitis - A Phase I Pilot Study in Adults
Lead sponsor
Oregon Health and Science University
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2005
Completion date
May 31, 2006
Enrollment
10 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dermatitis, atopic